Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
Shares of Roche gain as it says arthritis drug can lessen need for ventilators in COVID-19 patients
11:42am, Friday, 18'th Sep 2020
Shares of Roche Holding AG undefined gained 1.9% in premarket trading on Friday after the drug maker said hospitalized COVID-19 patients taking rheumatoid...
Encouraging Results from Phase 2 Trial of Retifanlimab in Patients with Previously Treated, Advanced Squamous Cell Carcinoma of the Anal Canal
Analyst and investor conference call and webcast scheduled for Tuesday, September 29, 2020 at 9:00 a.m. EDT / 3:00 p.m. CEST PLANEGG/MUNICH and WILMINGTON, DE / ACCESSWIRE / September 17, 2020 / Morph
Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
12:00am, Thursday, 17'th Sep 2020
Incyte and MorphoSys to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients
05:57pm, Wednesday, 16'th Sep 2020
Lilly’s anti-inflammatory drug Olumiant reduced hospital stays when combined with Gilead’s remdesivir.
Bank of America Corp DE Reduces Position in Incyte Co. (NASDAQ:INCY)
07:03am, Wednesday, 16'th Sep 2020
Bank of America Corp DE lessened its holdings in shares of Incyte Co. (NASDAQ:INCY) by 2.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Coronavirus update: WHO says record number of new cases — 307,930 — counted worldwide on Sunday
05:31pm, Monday, 14'th Sep 2020
The World Health Organization said a record number of cases of the coronavirus that causes COVID-19 were recorded on Sunday around the world for a total of...
Eli Lilly Arthritis Drug Helped Hospitalized Covid-19 Patients Recover Faster
03:12pm, Monday, 14'th Sep 2020
Eli Lilly is seeking emergency-use authorization for the arthritis drug Olumiant after a study found it accelerated the recovery of hospitalized Covid-19 patients who were also treated with Gilead’s
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
11:48am, Monday, 14'th Sep 2020
Eli Lily & Co. undefined and Incyte Corp. undefined said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized...
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
07:48am, Monday, 14'th Sep 2020
Eli Lily & Co. LLY, +1.27% and Incyte Corp. INCY, -0.29% said Monday that their rheumatoid arthritis drug Olumiant helped reduce recovery time in hospitalized COVID-19 patients when it was used in com
Biotechs With Strong Balance Sheets
12:03pm, Wednesday, 09'th Sep 2020
Not all biotechs are created equal. Strong balance sheets can separate the weak from the strong.
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that Massachusetts General Cancer Center is the recipient of the first Incyte Ingenuity Award, an annual program that was create
Calithera Terminating Partnership, And Other News: The Good, Bad And Ugly Of Biopharma
07:27am, Wednesday, 09'th Sep 2020
Calithera signals terminating partnership with Incyte. Lexicon reports dosing in Phase 2 clinical study for LX9211.
Incyte (INCY) Down 2.2% Since Last Earnings Report: Can It Rebound?
11:31am, Thursday, 03'rd Sep 2020
Incyte (INCY) reported earnings 30 days ago. What's next for the stock?
WILMINGTON, Del.--(BUSINESS WIRE)--Pivotal GEOMETRY mono-1 Study Results of Capmatinib (Tabrecta™) in Patients with METex14 Metastatic Non-Small Cell Lung Cancer Published in NEJM
